Overview:
Proton pump inhibitors are medications that are used to reduce stomach acid levels for a long time in people who have gastroesophageal reflux disease, hyperacidity and ulcers. Proton pump inhibitors (PPIs) have a different mechanism of action as they are supplied in a non-lipophilic way to the environment and easily cross the cell membrane into intracellular compartments such as the parietal cell canaliculus with acidic areas, and the inactive drug is indicated and rearranged into its active in acidic environments and irreversibly blocks the gastric proton pump of the gastric parietal cells.
The global proton pump inhibitors market is estimated to be valued around US$ 2.9 billion in 2020 and is expected to register a CAGR of 4.30% over the forecast period (2020-2027).
Request Here Sample with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/4225
Drivers:
Rising incidence of obesity in adults and adolescents, is expected to drive growth of the global proton pump inhibitors market during the forecast period. For instance, in 2017, according to the U.S. National Library of Medicine report, individuals with higher body mass index (BMI) have a higher risk of gastrointestinal diseases such as gastroesophageal reflux disease and can lead to esophageal erosions.
Moreover, increasing incidence of gastrointestinal diseases including duodenal ulcers, barrets esophagus, and non-erosive reflux disease (NERD) are expected to propel growth of the global proton pump inhibitors market over the forecast period. For instance, in July 2020, according to the U.S. National Library of Medicine report published, around 60% of people were suffering from non-erosive reflux disease (NERD) and 30% of people were suffering from barrets esophagus in the U.S.
Impact of Coronavirus (COVID-19):
Since the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries around the world and the World Health Organization has declared it a public health emergency. For instance, according to a World Health Organization report, exposure to coronavirus (COVID-19) has resulted in around 34,804,348 infected people globally since 4 October 2020.
COVID-19 can affect in three main ways; by directly affecting production and demand; by creating disruption to distribution channels; and its financial impact on financial firms and markets. Supply chain and manufacturing operations in India, China, and the U.S. have been damaged due to nationwide lockdowns. While countries including Saudi Arabia, UAE, Egypt, and others are facing problems regarding drug trafficking from one place to another place. Moreover, people who have been taking proton pump inhibitors medication for a long time may become infected with COVID-19. For instance, in August 2020, according to the National Library of Medicine Report published, use of proton pump inhibitors can increase risk of COVID-19. Furthermore, people who use proton pump inhibitors twice daily are more likely to be infected with COVID-19. These factors are hinder the growth of global proton pump inhibitors market. Therefore, the COVID-19 epidemic has also disrupted the global proton pump inhibitors market in the negative way.
Get PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/4225
Key Takeaways of the Global Proton Pump Inhibitors Market:
The global proton pump inhibitors market is expected to register a CAGR around 4.30%over the forecast period due to rising numbers of product approvals and launches and rising incidence of gastrointestinal diseases such as GERD and duodenal ulcers.
Among type, the Omeprazole segment is expected to hold a highest market position in 2020, due to a significant rise in launch of generics of omeprazole by local and generic manufacturing pharmaceutical companies.
On the basis of disease indication, gastroesophageal reflux disease segment hold a higher market share in 2020 due to increasing incidence of gastroesophageal reflux disease in children and adults globally.
key players dominating in the global proton pump inhibitors market such as AstraZeneca PLC/AB, Pfizer Inc., Bayer AG, Eisai Pharmaceuticals India Pvt. Ltd, Cadila Pharmaceuticals Limited, Santarus, Inc., Janssen Pharmaceuticals, Wyeth, LLC, Takeda Pharmaceutical Company Limited, Aurobindo Pharma, Perrigo Company plc, Sanofi S.A, Dr. Reddy’s Laboratories, RedHill Biopharma Ltd (ADR), Cipla Limited and Aralez Pharmaceuticals Inc.
Reasons to Purchase this Report
• Current and future of global Proton Pump Inhibitors market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Disease Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Technological Evolution
- Regulatory Scenario
- Key Developments
- Collaboration and Acquisition
- Diagnosis Rate/Ratio
- Pipeline Analysis
- PEST Analysis
- Reimbursement Scenario
- Market Dynamics
- Global Proton Pump Inhibitors Market, Impact of COVID-19 Pandemic
- COVID-19 Impact
- Economic Impact
- Demand and Supply Impact Analysis
- Global Proton Pump Inhibitors Market, By Type, 2016-2027 (US$ Bn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Omeprazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
- Pantaprazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
- Rabeprazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
- Dexlansoprazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
- Lansoprazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
- Omeprazole
- Introduction
- Global Proton Pump Inhibitors Market, By Disease Indication, 2016–2027 (US$ Bn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Ulcers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
- Gastesophageal Reflux Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
- Ulcers
- Introduction
- Global Proton Pump Inhibitors Market, By Distribution Channel, 2016–2027 (US$ Bn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Bn)
- Hospital Pharmacies
- Segment Trends
- Introduction
- Global Proton Pump Inhibitors Market, By Region, 2016–2027 (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Countries, 2017–2027
- North America
- Introduction
- Market Size and Forecast, By Type, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Disease Indication, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Disease Indication, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Disease Indication, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Disease Indication, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Disease Indication, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Disease Indication, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Bn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- AstraZeneca PLC/AB
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cadila Pharmaceuticals Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eisai Pharmaceuticals India Pvt. Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Santarus, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Wyeth, LLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Janssen Pharmaceutica
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Takeda Pharmaceutical Company Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aurobindo Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Perrigo Company plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dr. Reddy’s Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aralez Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- RedHill Biopharma Ltd (ADR)
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cipla Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AstraZeneca PLC/AB
- Company Profiles
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837